Lynch Asset Management’s DexCom DXCM Stock Holding History

Lynch Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,300	Closed	-$588K	–	48
2023 Q3	$588K	Sell	6,300 -1,100	-15%	-$124K	0.39%	39
2023 Q2	$951K	Sell	7,400 -600	-8%	-$72.6K	0.61%	36
2023 Q1	$929K	Sell	8,000 -3,700	-32%	-$414K	0.67%	35
2022 Q4	$1.32M	Sell	11,700 -300	-3%	-$32.9K	1.14%	32
2022 Q3	$965K	Hold	12,000	–	–	0.87%	32
2022 Q2	$895K	Buy	12,000 +2,600	+28%	+$237K	0.73%	33
2022 Q1	$1.2M	Hold	9,400	–	–	0.86%	29
2021 Q4	$1.26M	Buy	+9,400	New	+$1.35M	0.88%	30

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lynch Asset Management's DXCM Position: Q4 2023 in Review

Lynch Asset Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 6,300 shares — an estimated $588K sold.

Lynch Asset Management first reported a position in DXCM in Q4 2021 and held it in 8 quarters. The position peaked at $1.32M in Q4 2022. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Lynch Asset Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Lynch Asset Management sold 6,300 DexCom shares in Q4 2023, an estimated $588K.
Lynch Asset Management first reported a position in DexCom in Q4 2021 and held it in 8 quarters.
Lynch Asset Management's DexCom position peaked at $1.32M in Q4 2022.
974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Lynch Asset Management's 13F filing for Q4 2023, filed 26 Jan 2024.